How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension

European Respiratory Journal

Volumn 50, Issue 2, 2017, Pages

  Vanderpool, Rebecca R ^a   Desai, Ankit A ^a   Knapp, Shannon M ^a   Simon, Marc A ^b   Abidov, Aiden ^c   Yuan, Jason X J ^a   Garcia, Joe G N ^a   Hansen, Lillian M ^a   Knoper, Steven R ^a   Naeije, Robert ^d   Rischard, Franz P ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; PROSTACYCLIN; TREPROSTINIL; ANTIHYPERTENSIVE AGENT;

ADULT; BLOOD SAMPLING; CARDIAC INDEX; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG DOSE TITRATION; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART OUTPUT; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE ENDSYSTOLIC VOLUME; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE VOLUME; HEART STROKE VOLUME; HOSPITAL DISCHARGE; HUMAN; LETTER; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MALE; MIDDLE AGED; PRESSURE VOLUME CURVE; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RIGHT VENTRICULAR PRESSURE; SIX MINUTE WALK TEST; TREATMENT OUTCOME; AGED; DRUG EFFECT; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; STATISTICAL MODEL;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LINEAR MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR FUNCTION, RIGHT;

EID: 85049670203     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00764-2017     Document Type: Letter

References (15)

1. Galiè N, Palazzini M, Manes A. Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. Eur Heart J 2010; 31: 2080-2086.
2. Vonk-Noordegraaf A, Haddad F, Chin KM, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol 2013; 62: Suppl. 25, D22-D33.
3. Rich S, McLaughlin VV. The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension. J Am Coll Cardiol 1999; 34: 1184-1187.
4. Metsa-Ketela T. Cyclic AMP-dependent and -independent effects of prostaglandins on the contraction-relaxation cycle of spontaneously beating isolated rat atria. Acta Physiol Scand 1981; 112: 481-485.
5. Ueno Y, Okazaki S, Isogaya M, et al. Positive inotropic and chronotropic effects of beraprost sodium, a stable analogue of prostacyclin, in isolated guinea pig myocardium. Gen Pharmacol 1996; 27: 101-103.
6. Galiè N, Humbert M, Vachiery J-L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Respir J 2015; 46: 903-975.
7. Vonk Noordegraaf A, Westerhof BE, Westerhof N. The relationship between the right ventricle and its load in pulmonary hypertension. J Am Coll Cardiol 2017; 69: 236-243.
8. Kerbaul F, Brimioulle S, Rondelet B, et al. How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. Am J Respir Crit Care Med 2007; 175: 846-850.
9. Benza RL, Tapson VF, Gomberg-Maitland M, et al. One-year experience with intravenous treprostinil for pulmonary arterial hypertension. J Heart Lung Transplant 2013; 32: 889-896.
10. Vanderpool RR, Pinsky MR, Naeije R, et al. RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension. Heart 2015; 101: 37-43.
11. Brimioulle S, Wauthy P, Ewalenko P, et al. Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol 2003; 284: H1625-H1630.
12. Trip P, Rain S, Handoko ML, et al. Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension. Eur Respir J 2015; 45: 1603-1612.
13. Vanderpool RR, Rischard F, Naeije R, et al. Simple functional imaging of the right ventricle in pulmonary hypertension: Can right ventricular ejection fraction be improved? Int J Cardiol 2016; 223: 93-94.
14. Rex S, Missant C, Segers P, et al. Epoprostenol treatment of acute pulmonary hypertension is associated with a paradoxical decrease in right ventricular contractility. Intensive Care Med 2008; 34: 179-189.
15. Kass DA, Maughan WL. From 'Emax' to pressure-volume relations: a broader view. Circulation 1988; 77: 1203-1212.